logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12115218 B1

PDFFull Text
Date of Patent:
Oct. 15, 2024

Filed:

Apr. 17, 2019

Immunological adjuvant composition, preparation method and application thereof

Applicant:

Luoyang Seiwei Biotechnologies Co., Ltd., Hanan, CN;

Inventors:

Kegong Tian, Henan, CN;

Yongmei Liu, Henan, CN;

Xuke Zhang, Henan, CN;

Assignee:

LUOYANG SEIWEI BIOTECHNOLOGIES CO., LTD., Luoyang, CN;

Attorneys:

John A. Miller

Shumaker, Loop & Kendrick, LLP

Primary Examiner:

Shanon A Foley

Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01); A61K 39/187 (2006.01); A61K 39/245 (2006.01); A61P 31/04 (2006.01); A61P 31/20 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/0241 (2013.01); A61K 39/12 (2013.01); A61K 39/187 (2013.01); A61K 39/245 (2013.01); A61P 31/04 (2018.01); A61P 31/20 (2018.01); A61K 2039/5252 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55577 (2013.01);
Abstract

The present disclosure provides an adjuvant composition containing 0.2%-15% w/v carbomer, 0.1%-0.5% w/v lecithin, and 0.03%-0.2% w/v ginsenoside. The adjuvant composition of the present disclosure cannot only ensure the long-term clarification and/or stability of the vaccine, but also can effectively stimulate the inactivated antigens and subunit antigens therein to produce high-titer antibodies for immune protection. The inactivated vaccines or subunit vaccines prepared by the adjuvant composition of the present disclosure can be used as a diluent for freeze-dried live virus antigens and has no toxic effect on the live virus antigens.

Find Patent Forward Citations

Tian, Kegong. (2024). Immunological adjuvant composition, preparation method and application thereof (U.S. Patent No. 12115218). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12115218

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…